Literature DB >> 27504975

Evaluation of the Western blotting method for the diagnosis of congenital toxoplasmosis.

Jaqueline Dario Capobiango1, Thaís Cabral Monica2, Fernanda Pinto Ferreira3, Regina Mitsuka-Breganó4, Italmar Teodorico Navarro4, João Luis Garcia4, Edna Maria Vissoci Reiche5.   

Abstract

OBJECTIVE: To evaluate the Western blotting method for the detection of IgG anti-Toxoplasma gondii (T. gondii) (IgG-WB) in the serum of children with suspected congenital toxoplasmosis.
METHODS: We accompanied 47 mothers with acquired toxoplasmosis in pregnancy and their children, between June of 2011 and June of 2014. The IgG-WB was done in house and the test was considered positive if the child had antibodies that recognized at least one band on IgG blots different from the mother's or with greater intensity than the corresponding maternal band, during the first three months of life.
RESULTS: 15 children (15.1%) met the criteria for congenital toxoplasmosis and 32 (32.3%) had the diagnosis excluded. The symptoms were observed in 12 (80.0%) children and the most frequent were cerebral calcification in 9 (60.0%), chorioretinitis in 8 (53.3%), and hydrocephalus in 4 (26.6%). IgM antibodies anti-T. gondii detected by chemiluminescence (CL) were found in 6 (40.0%) children and the polymerase chain reaction (PCR) for detection of T. gondii DNA was positive in 5 of 7 performed (71.4%). The sensitivity of IgG-WB was of 60.0% [95% confidence interval (CI) 32.3-83.7%] and specificity 43.7% (95% CI 26.7-62.3%). The sensitivity of IgG-WB increased to 76.0 and 89.1% when associated to the research of IgM anti-T. gondii or PCR, respectively.
CONCLUSIONS: The IgG-WB showed greater sensitivity than the detection of IgM anti-T. gondii; therefore, it can be used for the diagnosis of congenital toxoplasmosis in association with other congenital infection markers.
Copyright © 2016 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Congenital Toxoplasmosis; Diagnosis; Diagnóstico; Serology; Sorologia; Toxoplasmose Congênita; Western Blotting; Western blotting

Mesh:

Substances:

Year:  2016        PMID: 27504975     DOI: 10.1016/j.jped.2016.02.014

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  5 in total

1.  Congenital Toxoplasmosis in Tunisia: Prenatal and Neonatal Diagnosis and Postnatal Follow-up of 35 Cases.

Authors:  Yosr Boudaouara; Karim Aoun; Rania Maatoug; Olfa Souissi; Aïda Bouratbine; Rym Ben Abdallah
Journal:  Am J Trop Med Hyg       Date:  2018-04-12       Impact factor: 2.345

2.  Specific antibody titer decay in neonates prenatally exposed to Toxoplasma gondii and their mothers.

Authors:  Serena Salomè; Claudia Grieco; Pasquale Fabio Barra; Eleonora Capone; Fiorentino Grasso; Francesca Carraturo; Pasquale Dolce; Paola Salvatore; Letizia Capasso; Francesco Raimondi
Journal:  Ital J Pediatr       Date:  2022-05-03       Impact factor: 3.288

3.  Maternal Anti-Toxoplasma Treatment during Pregnancy Is Associated with Reduced Sensitivity of Diagnostic Tests for Congenital Infection in the Neonate.

Authors:  Hélène Guegan; Tijana Stajner; Branko Bobic; Cindy Press; Rares T Olariu; Kjerstie Olson; Jelena Srbljanovic; Jose G Montoya; Olgica Djurković-Djaković; Florence Robert-Gangneux
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

Review 4.  Protein purification and analysis: next generation Western blotting techniques.

Authors:  Manish Mishra; Shuchita Tiwari; Aldrin V Gomes
Journal:  Expert Rev Proteomics       Date:  2017-10-13       Impact factor: 3.940

5.  Immunogenicity and protection efficacy of enhanced fitness recombinant Salmonella Typhi monovalent and bivalent vaccine strains against acute toxoplasmosis.

Authors:  Fei-Kean Loh; Sheila Nathan; Sek-Chuen Chow; Chee-Mun Fang
Journal:  Pathog Glob Health       Date:  2021-02-01       Impact factor: 2.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.